Biohaven .(US:BHVN) Prnewswireยท2025-08-18 12:45Group 1 - The Gross Law Firm has issued a notice to shareholders of Biohaven Ltd. regarding a class action lawsuit related to misleading statements made by the company during the class period from March 24, 2023, to May 14, 2025 [1] - Allegations include that Biohaven overstated the regulatory prospects of its product candidate, troriluzole, and the efficacy of BHV-7000 for bipolar disorder, which could negatively impact the company's business and financial condition [1] - Shareholders are encouraged to register for the class action by the deadline of September 12, 2025, to potentially be appointed as lead plaintiff and receive updates on the case [2] Group 2 - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, aiming to ensure responsible business practices [3] - The firm seeks recovery for investors who suffered losses due to false or misleading statements that artificially inflated the company's stock [3]